Ordering Venofer for a 24-Week Pregnant Woman
For a 24-week pregnant woman with iron deficiency anemia, order Venofer (iron sucrose) 200 mg IV diluted in 100 mL normal saline, infused over 15 minutes, given on 5 separate occasions over a 14-day period (total dose 1000 mg). This is the FDA-approved dosing regimen for non-dialysis dependent patients, which includes pregnant women 1.
Dosing Protocol
The standard regimen consists of:
- Dose per infusion: 200 mg elemental iron
- Dilution: Mix in maximum 100 mL of 0.9% normal saline
- Infusion rate: Administer over 15 minutes
- Frequency: 5 doses given over 14 days
- Total cumulative dose: 1000 mg
Alternatively, you can administer 200 mg undiluted as a slow IV push over 2-5 minutes, though infusion is generally preferred for safety monitoring 1.
Timing Considerations
Administer Venofer as early as possible in the third trimester for optimal benefit. Recent evidence demonstrates that administration before 34 weeks gestation produces superior hemoglobin responses compared to later administration (mean increase 2.5 g/dL vs 1.3 g/dL, p<0.001) 2. At 24 weeks, this patient is ideally positioned to receive maximum benefit, as:
- Doses ≥800 mg with ≥6-8 weeks latency before delivery show the strongest hemoglobin improvement (2.6-3.1 g/dL increase) 2
- Mean hemoglobin increases of 1.5-3.2 g/dL are consistently achieved 3, 4, 5, 6, 7
- Iron stores remain replenished at 6 months post-infusion 7
Safety Precautions
Monitor the patient for 30 minutes after each infusion and ensure resuscitation equipment is immediately available 1. Key safety points:
- No fetal heart rate monitoring is required during or after infusion 8, 6
- Serious adverse reactions are extremely rare in pregnancy—a recent series of 417 pregnant patients showed no anaphylactic reactions 6
- Minor side effects occur in only 11.5% of patients (dizziness 6.2%, headache 1.9%, hypotension 1.7%) 6
- Avoid administration before 13 weeks gestation due to lack of safety data 8
Contraindications and Precautions
Do not administer if:
- Known hypersensitivity to Venofer 1
- Evidence of iron overload (check baseline ferritin and transferrin saturation)
- Gestational age <13 weeks 8
Monitoring Parameters
Check CBC and iron parameters 4-8 weeks after the last infusion 8. Do not check iron studies within 4 weeks of completing therapy, as circulating iron interferes with assays 8. Expected response:
- Hemoglobin should increase by 1-2 g/dL within 4-8 weeks 8
- Target ferritin ≥50 ng/mL in absence of inflammation 8
- Transferrin saturation should normalize (>20%) 8
Advantages Over Oral Iron
Venofer is particularly appropriate at 24 weeks because:
- Rapid correction: Achieves therapeutic hemoglobin levels faster than oral iron (significant increase by 14 days vs 28+ days) 4, 9, 5
- Superior compliance: Eliminates daily oral therapy and gastrointestinal side effects that plague oral iron 5, 6
- Adequate time for response: Allows 16 weeks before term delivery for full hematologic response and iron store replenishment
- Proven safety: Multiple studies confirm safety in pregnancy with no increased adverse maternal or neonatal outcomes 8, 6
Clinical Pitfalls to Avoid
- Don't delay treatment: Earlier administration (<34 weeks) produces significantly better outcomes 2
- Don't underdose: The full 1000 mg course is needed for adequate iron repletion; single doses are insufficient 2
- Don't check labs too early: Wait 4-8 weeks post-infusion for accurate assessment 8
- Don't require fetal monitoring: This is unnecessary and not recommended 8, 6
The evidence strongly supports that IV iron sucrose is safe, effective, and can be administered in outpatient obstetric clinics without specialized infusion center resources 6.